Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Contact information

Email
james.larkin@psych.ox.ac.uk

Telephone
+44 (0)1865 618296

ORCID
https://orcid.org/0000-0002-4169-8447

Research groups

Oxford Precision Psychiatry Lab

Colleges

Trinity College

James Larkin

PhD FHEA

Project Manager for PRADA trial

Key publications

Metabolomic Biomarkers in Blood Samples Identify Cancers in a Mixed Population of Patients with Nonspecific Symptoms.

Larkin JR. et al, (2022), Clin Cancer Res, 28, 1651 - 1661

Improving Delineation of True Tumor Volume With Multimodal MRI in a Rat Model of Brain Metastasis.

Larkin JR. et al, (2020), Int J Radiat Oncol Biol Phys, 106, 1028 - 1038

Quantitative blood flow measurement in rat brain with multiphase arterial spin labelling magnetic resonance imaging.

Larkin JR. et al, (2019), J Cereb Blood Flow Metab, 39, 1557 - 1569

A type 2 biomarker separates relapsing-remitting from secondary progressive multiple sclerosis.

Dickens AM. et al, (2014), Neurology, 83, 1492 - 1499

Recent publications

Diffusion skewness imaging using Q-space trajectory imaging with positivity constraints.

Li J. et al, (2026), Phys Med Biol, 71

Integrating NMR Metabolomics and Glycomics for Early Cancer Detection in Patients with Non-Specific Symptoms

Kacerova T. et al, (2026)

Informed Dictionary-Guided Monte Carlo Inversion for Robust and Reproducible Multidimensional MRI.

Park JS. et al, (2025), Magn Reson Med

More publications